Purpose The role of body size in prostate cancer etiology is unclear and potentially varies by age and disease subtype. We investigated whether body size in childhood and adulthood, including adult weight change, is related to total, low-intermediate-risk, high-risk, and fatal prostate cancer. Methods We used data on 1,499 incident prostate cancer cases and 1,118 population controls in Sweden. Body figure at age 10 was assessed by silhouette drawings. Adult body mass index (BMI) and weight change were based on self-reported height and weight between ages 20 and 70. We estimated odds ratios (ORs) with 95 % confidence intervals (CIs) by unconditional logistic regression.
Introduction
Prostate cancer is a growing public health concern worldwide. The highest incidence is found in Western countries, and migrant studies indicate that lifestyle factors are etiologically important [1] . Although few such causal factors have been established, the epidemic growth of overweight and obesity might play a role. Body size influences multiple hormonal and metabolic pathways that may influence tumorigenesis. Although findings are inconsistent, an increasing body of evidence suggests that body size is related to prostate cancer [2] [3] [4] [5] [6] [7] . However, the relationship appears complex and dependent on age of exposure and disease subtype, and much remains to be clarified.
Early-life exposure has potentially greater influence on prostate cancer development considering the long latency period of the disease. Previous studies on childhood body size and prostate cancer are few with mixed results [6] , although three studies suggested a protective effect of childhood obesity [8] [9] [10] . Body size in early adulthood (B30 years) has also been little investigated, with inconsistent findings [10] [11] [12] [13] [14] . As regards obesity in middle to late adulthood, recent data suggest positive associations with high-risk and fatal prostate cancer, but an inverse relationship with low-risk disease [2, 3, 5, 15] . Weight gain during adulthood might increase prostate cancer risk [16] [17] [18] , whereas weight loss may reduce the risk [19] , although the evidence is inconclusive. Adult height has been positively associated with the disease [5, 7, 13, 20, 21] .
Our study aims to look comprehensively at body size and prostate cancer from a life-course perspective. In a large population-based case-control study, we assessed body figure at age 10, adult height, body mass index (BMI) in early, middle, and late adulthood, as well as adult weight change. Because prostate cancer is heterogeneous and prevention of aggressive and fatal disease is of critical concern, we examined the association between each anthropometric measure and total, low-intermediate-risk, high-risk, and fatal disease.
Subjects and methods

Study population
The Cancer of the Prostate in Sweden (CAPS) study has been comprehensively described elsewhere [22, 23] . Incident cases of histologically confirmed prostate cancer were identified from four of the six regional cancer registries in Sweden, capturing virtually all incident cancers in those geographic areas. Clinical data were acquired from the National Prostate Cancer Registry, covering 95 % of the cases. Cases were 35-79 years at enrollment (January 2001-September 2002) and lived in the central and north of Sweden. Controls, frequency-matched by age (5-year intervals) and region of residence, were randomly selected from the Swedish Population Registry; invitations were mailed every month except July-August to reflect the continuous enrollment of cases. Out of 1,895 eligible cases and 1,694 invited controls, 1,499 (79 %) cases and 1,130 (67 %) controls completed a questionnaire. The average time between cancer diagnosis and sending out the questionnaire was 5 months. To improve response rate, cases and controls not responding to the initial invitation were recontacted three times (by follow-up letter, new questionnaire, and phone call). All participants provided written informed consent at enrollment. The study was approved by the ethics committees at Karolinska Institutet and Umeå University.
Prostate cancer subtypes were defined by high or low likelihood of tumor progression according to the guidelines of the European Association of Urology [24] . High-risk prostate cancer was defined as cases meeting at least one of the following criteria at diagnosis: tumor, nodes, metastasis (TNM) stage T3/T4, N ? , or M ? ; Gleason score 8-10; or serum prostate-specific antigen (PSA) C20 ng/ml. Lowintermediate-risk disease was defined as T1/T2, N0/X, M0/ X, Gleason score 2-7, and PSA \20 ng/ml at diagnosis. In supplementary analyses, low-risk (T1/T2, N0/X, M0/X, Gleason score 2-6, and PSA \10 ng/ml) and intermediaterisk cases (T1/T2, N0/X, M0/X, and Gleason score 7 or PSA 10 to\20 ng/ml) were separated. Fatal cases were defined by prostate cancer-specific death during follow-up through December 2010, with a median follow-up time of 8.8 years.
Questionnaire assessment
Anthropometric measures were based on the self-administered questionnaire filled in at study entry. Body figure at age 10 was assessed by a pictogram with body silhouette drawings of five different sizes (Fig. 1). Participants filled in open-ended questions on current height and weight as well as recalled weight at age 20, 30, 40, 50, 60, 65, and 70, or up to current age.
Usual dietary intake during the previous year was assessed by a semiquantitative 106-item food frequency questionnaire (FFQ) described in detail elsewhere [22, 25] . Total energy, food, and nutrient intake from almost identical FFQs have been validated against repeated weighed food records and 24-h recall interviews in two Swedish study populations [26, 27] . The questionnaire-based energy intake agreed within 8 % with the estimated intake from 24-h recalls [27] . Energy and nutrient intakes were estimated through linkage to the Swedish National Food Administration database [28] . Physical activity was assessed as occupational activities, walking/bicycling, exercise, and household/leisure-time activities at age 15, 30, 50, and 65, as described previously [29] . Validation against two 7-day activity diaries generated a Spearman correlation coefficient of r = 0.56 [30] . We calculated metabolic equivalents (METs) in hours per day spent in moderate or vigorous activities (MET C3) [31] by multiplying the reported time for each activity by the assigned MET value [30] . We calculated age-specific physical activity as the mean of previous ages, e.g., for age 30, we took the mean of activity levels at ages 15 and 30. The questionnaire further assessed demographic characteristics as well as health factors such as tobacco use, history of diabetes, and family history of prostate cancer.
Statistical methods
Participants with incomplete questionnaires were excluded (n = 67), leaving 2,617 subjects (1,499 cases and 1,118 controls) in the final analyses. Baseline characteristics were compared using the Wilcoxon-Mann-Whitney test for continuous variables and the v 2 test for categorical variables. The proportion of missing answers on anthropometric measures was consistently higher among controls than among cases, ranging from 1 % (height) to 38 % (BMI age 40) among controls, and from 0 % (height) to 29 % (BMI age 40) among cases. Correlations between exposures were estimated by Spearman correlation coefficients for continuous variables and Kendall Tau rank correlation coefficients for categorical variables.
We categorized adult height into quartiles based on the distribution among controls, and body figure at age 10 into four categories, combining drawings 4 and 5, since few individuals were in the obese group (n = 29). We calculated age-specific BMI (kg/m 2 ) as well as the mean BMI over ages 20-70 (excluding age 65 so that BMI was not weighted toward later ages, because the reporting interval was 10 years between ages 20 and 60 and 5 years between ages 60 and 70) and categorized BMI as follows: \22.5, 22.5 to \25, 25 to \27.5, and C27.5. Weight change throughout adulthood was measured in two ways. First, we calculated total change as the last recalled weight minus the first and categorized that difference into four groups: weight loss (C2 kg), stable weight (-1.9 to ? 4.9 kg), modest weight gain (5 to \15 kg), and large weight gain (C15 kg). Secondly, we modeled BMI against age (20-70 years) using linear regression for each individual to estimate beta coefficients corresponding to the average linear change in BMI units per year; the beta coefficient was categorized based on tertile distribution among the controls. All anthropometric variables were modeled categorically in relation to prostate cancer risk. Height, BMI, and adult weight change were also modeled continuously as the effect of a 5-unit increment on prostate cancer risk.
Using unconditional logistic regression, we estimated odds ratios (ORs) with 95 % confidence intervals (CIs) for total prostate cancer as well as low-intermediate-risk (n = 671), high-risk (n = 748), and fatal (n = 343) disease. Supplementary analyses were performed separating low-risk (n = 393) and intermediate-risk (n = 278) disease. All models were adjusted for age and region of residence. Multivariate-adjusted models were additionally adjusted for family history of prostate cancer (height and weight change), physical activity (weight change), age at the first reported weight (weight change), and time span between the first and last recalled weight (mean adult BMI and weight change). Potential confounders were selected based primarily on subject matter knowledge, including causal diagrams [32] , and secondly on whether substantial changes in estimates were observed when the covariates were included one by one. Adding two different sets of a priori-selected covariates (I: energy intake, physical activity, education, history of diabetes, and family history of prostate cancer; and II: smoking, alcohol, total fat, calcium, fatty fish, tomato products, coffee, red meat, fruit and vegetables, and sweet foods) did not change the results substantially. Other covariates not included in the final models were height, birth weight, employment status, and marital status. Furthermore, we mutually adjusted for adult BMI in models of childhood body shape and vice versa, as well as for previous BMI in models of age-specific BMI.
To explore potential interaction, we included multiplicative interaction terms in logistic regression models, and secondly, we modeled the stratified effect across categories of the potential effect modifier using interaction indicator variables. Age and family history of prostate cancer are related to hereditary disease and have previously been shown to modify the association between BMI and prostate cancer [12] . We further hypothesized that the association between body size and prostate cancer may diverge between diabetic and nondiabetic men, active and inactive men, or men with high and low energy intake, due to metabolic and/or endocrine differences between these groups of men. Additionally, we tested interaction between weight change and both height and BMI at the first recalled weight.
We performed sensitivity analysis on mean BMI and weight change to make sure that missing or implausible values did not substantially affect the representation of these variables. In models of mean BMI and total weight change, we excluded individuals with a time span \20 years between first and last recalled weight, since we aimed to capture long-term weight change. We also excluded men with BMI \16 at the age of the first recalled weight, since an extremely low weight at the start, likely caused by underreports or underlying disease, can produce a distortedly large weight gain. In models of the average linear change in BMI, we excluded individuals with a time span \20 years or BMI \16 at any age, or with R 2 \0.5 in the linear regression models for each individual (a low R 2 indicating a bad fit between the data and the regression line). To further assess the impact of missing values on the estimates, we ran multiple imputation chain equation (MICE) [33] on all models, assuming missing at random.
We assessed the statistical significance by Wald and likelihood ratio tests (p \ 0.05, two-sided tests) and goodness of fit based on the Hosmer-Lemeshow and Pearson v 2 tests. Analyses were performed in the statistical software systems SAS 9.3 (SAS Institute Inc.) and Stata 12 (StataCorp LP).
Results
Characteristics of the cases and controls are presented in Table 1 . Cases were slightly younger, were more likely to live in northern Sweden, be employed, and have a family history of prostate cancer and had a slightly higher intake of energy and alcohol, as compared to controls. The two groups did not differ by education, history of diabetes, smoking status, or physical activity level. The mean height was 176.8 and 176.0 in cases and controls, respectively, and both groups had a mean adult BMI of 24.2 kg/m 2 , a mean total weight change of ?11.7 kg, and a mean linear change in BMI of 0.1 kg/m 2 /year. Childhood body figure was weakly correlated with adult BMI at any age ( Table 2 ). In contrast, adult BMI at different ages correlated strongly if close in age, and weakly to moderately for ages further apart (r = 0.30-0.87). Both variables of weight change correlated more strongly with BMI in late adulthood than in early adulthood and correlated weakly with mean adult BMI.
We found a statistically significant increased risk of total prostate cancer for the three highest quartiles of height compared to the lowest quartile (\172 cm), with ORs in the range 1.28-1.44 (Table 3) . Similar associations were seen for low-intermediate-risk and high-risk disease. We observed no trend across categories; however, a continuous increment of 5 cm was positively associated with total and low-intermediate-risk disease.
Men who reported being moderately thin (drawing 2) at age 10 had a 27 % lower risk of dying from prostate cancer compared to men in the normal-weight category, whereas men who reported being overweight or obese (drawing 4-5) had a 54 % increased risk of fatal disease (P trend = 0.01; Table 3) .
A mean BMI of 25 to \27.5 during adulthood was inversely associated with low-intermediate-risk disease (OR 0.75, 95 % CI 0.55-1.02) compared to BMI \22.5 (Table 3 ). Men with BMI 22.5 to \25 at age 20 had 20-30 % lower risk of all disease subtypes compared to BMI\22.5, and similar inverse associations were observed for BMI at age 30 and 40, especially for low-intermediaterisk disease (Table 3) . We found no significant associations with overweight or obesity at ages 20-40, nor did we observe any associations with BMI at age 50 or 60 (Table 3) .
Results for childhood body shape and adult BMI were overall similar between simple and multivariate-adjusted models (data not shown). Models adjusted for body size in previous or later age are presented in supplemental Table  S1 (Online Resource 1). Adjustment for young adult BMI strengthened the inverse associations between childhood thinness and total and low-intermediate-risk prostate cancer. Similarly, the inverse association between adult overweight and low-intermediate-risk disease became stronger and statistically significant after adjustment for childhood body shape. The inverse associations with low BMI at age 20-40 were stable when adjusted for childhood body size, but for age 30-40, they were attenuated when additionally adjusted for previous BMI. Total weight change during adulthood measured as categories in kilogram was not statistically significantly associated with prostate cancer risk (data not shown). For the average linear change in BMI across age, we observed a 25-30 % increased risk of all prostate cancer subtypes comparing the second to the lowest tertile, but no association in the highest tertile (data not shown).
The association between adult weight change and prostate cancer risk was modified by BMI at the first reported age, and the stratified results are presented in Table 4 . Among men who reported being thin (BMI\22.5) at the starting age, those who gained C5 kg during adulthood had an increased risk of low-intermediate-risk disease compared to men with stable weight. A similar, though nonsignificant, association was seen for total prostate cancer. Also, a modest linear increase in BMI over age (second compared to first tertile) was positively associated with total and low-intermediate-risk prostate cancer among men who were thin at the starting age. In contrast, for both measures of weight change, we observed inverse linear associations between weight gain and total and low-intermediate-risk disease among men who reported being less thin (BMI C22.5) at the start.
We also observed an interaction between the average linear change in BMI and height (P interaction = 0.02). Short men (\172 cm) with a linear increase in BMI had an increased risk of total prostate cancer (OR for the second tertile 1.94, 95 % CI 1.23-3.07, and for the third tertile 1.78, 95 % CI 1.09-2.89, as compared to the first tertile), whereas no association was seen in taller men (C172 cm; data not shown). Similar patterns of effect modification by height were seen for all three prostate cancer subtypes.
Age at inclusion, family history of prostate cancer, history of diabetes, energy intake, and physical activity did not modify the association between any anthropometric measure and prostate cancer in the present study (data not shown). In analyses separating low-risk and intermediaterisk disease, associations were more pronounced for the latter; however, the results were overall similar compared with low-intermediate-risk cases combined (data not shown). Sensitivity analyses on models of mean adult BMI and weight change yielded no substantial changes in the estimates, nor did multiple imputation analysis (data not shown).
Discussion
Our large, population-based case-control study failed to show any convincing associations between body size and prostate cancer. In light of multiple testing, the few statistically significant findings need cautious interpretation. However, they might also suggest causal links that deserve further investigation. In particular, moderate thinness in childhood, normal weight in the range of BMI 22.5 to \25 in early adulthood, or adult shortness, may reduce prostate cancer risk. Being on average slightly overweight in adulthood may reduce the risk of low-intermediate-risk disease. In contrast, childhood overweight may increase the risk of fatal disease, and modest adult weight gain may increase the risk of prostate cancer in men who are thin at start and in short men. Our study has several strengths. Besides its large size and population-based design, we achieved complete and rapid case ascertainment. PSA screening is not routinely implemented in Sweden, and the low proportion of PSA-detected cases in the CAPS study (*29 %) minimizes the risk of bias due to health-conscious men being more likely to be diagnosed at an early stage than less health-conscious individuals. Detailed clinical information at diagnosis and 8-10 years of mortality follow-up allowed analyses of prostate cancer subtypes, including fatal disease. In addition, the extensive questionnaire gave us the possibility of looking at several anthropometric measures in different periods in life, taking many potential confounders into consideration.
A potential limitation in our study is the self-reported and retrospective collection of anthropometric data. The use of body silhouettes is a simple and valid tool to assess body size [34] . In elderly individuals (71-76 years), recalled body silhouettes at age 10 has shown a correlation of r s = 0.44 with objectively measured body size at the same age [35] . Body silhouettes in childhood have been strongly associated with breast and colorectal cancer risk [36] [37] [38] . Nevertheless, the method does involve potential measurement error. Furthermore, self-reported anthropometric data in adulthood may entail overestimation of height and underestimation of weight and BMI [39] . Overweight/obese individuals tend to underreport their weight to a larger extent than normal-weight individuals [40, 41] , which may cause attenuation of potential associations between overweight/obesity and prostate cancer. This could potentially explain the weak results for adult BMI in the current study. However, self-reported height and weight have been highly correlated with measured values in men (r = 0.95 and r = 0.94, respectively) [34] . Also, in studies of men C50 years, recalled body weight at age 18-40 has been strongly correlated with measured weight (range of r = 0.71-0.95) [42, 43] . Although some exposure misclassification is unavoidable, notably in selfreported anthropometric measures from the distant past, it is most likely nondifferential since body size is not commonly believed to affect prostate cancer risk. Besides, we observed a clear trend of an average increase in BMI by 1 kg/m 2 every 10 years in both cases and controls, indicating that changes in body weight over time can be well captured by retrospective case-control data. Nonetheless, recall bias cannot be ruled out.
Selection bias is another potential concern because response rate was higher among cases (79 %) than among controls (67 %). The controls differed little from the cases with regard to healthy characteristics except for a lower alcohol and energy intake; however, selection bias may still be present. Residual or unmeasured confounding is also possible; however, our estimates were overall stable between simple and multivariate-adjusted models, also when including additional covariates in the models. We further addressed the potential issue of missing values by performing both sensitivity analyses and imputed analyses and conclude that missingness is not likely to have affected our estimates substantially. In MICE we assume missing at random; however, we cannot exclude the possibility of missing not at random that could potentially have biased our results.
The positive associations between adult height and various prostate cancer subtypes are in line with several previous studies [5, 7, 13, 20, 21] . A pooled analysis yielded relative risks of 1.06 (95 % CI 1.00-1.12) for localized disease and 1.09 (95 % CI 0.99-1.21) for advanced disease per 10-cm increment [5] , which is similar to the ORs per 5-cm increment observed in the present study.
A systematic review from 2008 reported only three studies on body size in childhood and prostate cancer [6] . A large American cohort study suggested a protective effect of self-perceived childhood overweight/obesity and advanced/metastatic prostate cancer [9] , although a recently updated analysis of these data did not confirm the early findings [Moller E et al. unpublished data]. Two American case-control studies have found inverse associations between obesity at age 10-13 and total or advanced prostate cancer [8, 10] . However, one case-control study of obesity in Chinese boys aged 8-9 [44] and three European case-control studies on adolescent body size reported no associations with total prostate cancer [45] [46] [47] . In contrast to previous studies, our results suggest an increased risk for fatal disease among men who were overweight or obese at age 10 compared to those of normal weight, and inverse associations with several disease subtypes in men who were moderately thin. The present study has a substantially larger sample size than the aforementioned case-control studies. Also, two of them did not separate the effect for different disease subtypes [8, 44] , whereas one was restricted only to advanced prostate cancer [10] .
Studies on obesity in adulthood have shown inconsistent findings, especially with regard to different subtypes of prostate cancer. For high BMI in middle to late adulthood, positive associations have been suggested for advanced/ high-grade disease [2, 3, 5, 16, 48, 49] and fatal disease [2, 11, 15, 16, 19, 50] , but an inverse association with localized/low-grade disease [3, 49] . Recent meta-analyses have yielded statistically significant relative risks in the range 1.09-1.15 for advanced and fatal prostate cancer for every 5 kg/m 2 increase in adult BMI [3, 5, 15] , and an equivalent relative risk of 0.94 for localized disease [3] . In line with the latter finding, we observed an inverse association with low-intermediate-risk prostate cancer in men with a mean adult BMI of 25 to \27.5 compared to BMI \22.5. However, we observed no association with total, high-risk, or fatal disease, nor with mean adult BMI C27.5 or BMI at age 50 and 60; this is consistent with previous null findings for BMI in middle to late adulthood [14, 21, 44, 51, 52] . Reverse causation is an unlikely explanation for the results of low-intermediate-risk disease, since these tumors are often early stage and not likely to have suffered diseaserelated weight loss.
Because development of clinical prostate cancer takes a long time, body size in early to middle adulthood (B40 years) might be more strongly associated with prostate cancer risk than body size in later ages. Few previous studies have focused on body size in early adulthood, and findings are mixed. Overweight or obesity between ages 18 and 30 has been shown to both increase and reduce prostate cancer risk, with no clear consistency regarding different disease subtypes [6, 11, 13, 18] . Our null findings for overweight between ages 20 and 40 are in line with other studies [44, [51] [52] [53] . We did, however, observe inverse associations between a healthy weight (BMI 22.5 to \25) in these ages and prostate cancer, as compared to a lower BMI. At large, differences in BMI cutoffs and definitions of prostate cancer subtypes may in part explain some of the discrepancies between studies.
The associations for adult BMI did not change when we adjusted for childhood body size. Adjusting for the mean of previous adult BMI in models of BMI at ages 30 and 40 weakened the observed associations, but did not change the results at age 50 or 60; this may indicate that body size at age 20 is the strongest predictor of prostate cancer risk in the present study. To our knowledge, only two previous studies on BMI in middle to late adulthood adjusted for BMI in early adulthood [11, 20] .
Several studies have found associations between weight change from early (18-25 years) to middle or late adulthood and prostate cancer risk [13, [16] [17] [18] [19] . In two studies, linear weight gain was positively associated with fatal disease, and weight gain in the range 5-20 kg between age 18 and middle age increased the risk of total and localized/ nonaggressive disease compared to stable weight (relative risks in the range 1.12-1.33) [16, 18] . Consistent with these findings, we found positive associations between moderate weight gain and total and low-intermediate-risk disease, though only in men with BMI \22.5 at start. However, results are conflicting since other studies have shown that weight gain from early to middle adulthood may increase the risk of advanced/high-grade prostate cancer [17] or reduce the risk of nonaggressive disease [13] , and weight loss has been seen to reduce the risk of nonmetastatic, high-grade prostate cancer [19] . Yet, other studies found no associations between weight change and prostate cancer [9, 14, 44, 51, 53, 54] . We observed higher risks of all disease subtypes among short men who gained weight. The divergent results across categories of start BMI and height are noteworthy and may deserve further investigation, although we cannot exclude the possibility that the observed interactions are due to chance.
A potential association between obesity and prostate cancer may be related to excess energy intake, although it is likely that obesity per se has effects independent of energy intake [55] . In the current study, total energy intake appeared to be neither a confounder nor an effect modifier.
Body size-induced fluctuations in hormone levels are biologically plausible risk factors for tumor development in the hormone-sensitive prostate gland. Hormones suggested to be involved are sex hormones, insulin, insulin-like growth factors, and adipokines [2, 4, 55, 56] . However, the most relevant time windows of exposure are still largely unknown. The most critical period is potentially before and during puberty, but also early adulthood is likely important as tumorigenic processes in prostatic tissue have been seen in men in their 20s [57] . Subsequently, weight throughout adulthood may potentially affect the progression of an initiated tumor. Also, attained height is determined by the hormonal environment in childhood and adolescence. The complex interactions between endocrine and metabolic pathways make the potential relationship between body size and prostate cancer a multifaceted picture; this complexity may to some extent explain the inconsistencies in current evidence of an association.
Body size has a potentially important role in prostate cancer prevention. The results of the present study provide some evidence of a beneficial effect of leanness in childhood and early adulthood as well as weight maintenance throughout adulthood. However, we cannot properly assess the relationship with early-life obesity, since the study participants were born mainly in the 1930-1940s and obesity was uncommon during their young ages.
We conclude that in this Swedish population the relationship between body size and prostate cancer depends both on disease subtype and on age of exposure. Our results should, however, be interpreted with caution as no clear dose-response was observed except for a few associations and considering the possible limitations related to the casecontrol design and the assessment of exposure. Body size early in life seems to be more important than body size late in life; hence, future studies on the role of body size in prostate cancer etiology clearly need to take the time window of exposure into consideration.
